NEWTOWN, Pa.--(BUSINESS WIRE)--BioClinica®, Inc. (NASDAQ: BIOC), a leading global provider of clinical trial management solutions, today announced its financial results for the first quarter ended March 31, 2011. Mark L. Weinstein, President and Chief Executive Officer of BioClinica said, “Our results for the quarter reflect our successful acquisition and organic growth strategies. Over the past three years we have transformed BioClinica into an integrated provider of a full suite of technology-enhanced clinical trial solutions including Medical Imaging Solutions, EDC, IVR/IWR and CTMS. This quarter represents our 5th consecutive quarter of year-over-year growth in service revenue, reflecting the traction we have made in the industry as clients look to us to provide a broad array of services.”
